Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Accenture
Cerilliant
AstraZeneca
Daiichi Sankyo
Johnson and Johnson
Julphar
Federal Trade Commission

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076224

« Back to Dashboard

NDA 076224 describes FLUTAMIDE, which is a drug marketed by Actavis Labs Fl Inc, Cipla Ltd, Mylan, Par Pharm, and Yaopharma Co Ltd, and is included in five NDAs. It is available from five suppliers. Additional details are available on the FLUTAMIDE profile page.

The generic ingredient in FLUTAMIDE is flutamide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flutamide profile page.
Summary for 076224
Tradename:FLUTAMIDE
Applicant:Mylan
Ingredient:flutamide
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 076224

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength125MG
Approval Date:May 9, 2003TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Federal Trade Commission
Argus Health
Medtronic
Baxter
Johnson and Johnson
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.